CTIS.eu › Cities › France › Angers Cedex 9
Angers Cedex 9
France
43 total trials
21 recruiting
2023-504628-24-00
4
2023-10-31
Huntington's Disease
2022-502966-26-01
5
2023-10-27
Sjögren’s syndrome
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
2022-501518-67-00
4
2023-08-10
High-risk and/or locally advanced prostate cancer
2022-500903-38-00
3
2023-02-09
unresectable hepatocellular carcinoma
2022-501901-10-00
6
2023-02-06
Chronic Hepatitis D Infection
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
2023-505341-23-00
5
2018-07-27
Non-muscle invasive bladder cancer
2023-505903-22-00
4
2024-07-02
Sepsis associated acute kidney injury
2022-502899-23-00
5
2024-04-23
Hepatic Encephalopathy (OHE)
2022-502467-38-00
4
2024-02-22
Non-small cell lung cancer (NSCLC)
2022-502313-28-00
4
2023-12-14
Diabetic Peripheral Neuropathic Pain
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
2022-501895-25-00
5
2023-09-13
Polymyalgia Rheumatica
2022-502366-25-00
5
2023-09-11
Food allergy
2022-502078-17-00
4
2022-12-15
unresectable hepatocellular carcinoma
2022-502392-37-00
4
2022-05-25
elderly patients (> = 60 years) with Acute Myeloid Leukemia
2022-500251-22-00
4
2018-04-12
This study will include all patients having received at least one infu
Showing 25–43 of 43 trials